Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Telix Pharmaceuticals (innovations) Pty Ltd

Clinical trials sponsored by Telix Pharmaceuticals (innovations) Pty Ltd, explained in plain language.

Targeted radiation attack tested for Tough-to-Treat prostate cancer

Disease control Terminated

This study tested whether adding a new targeted radiation drug to standard care could better control advanced prostate cancer that had spread and stopped responding to hormone therapy. The drug, 177Lu-DOTA-rosopatamab, is designed to seek out and deliver radiation directly to pro…

Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Ltd • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC